Match ends, Ajax 3, Shelbourne 1. Attempt missed. Anton Gaaei (Ajax) right footed shot from the centre of the box misses to the right. Assisted by Oliver Edvardsen with a cross. Attempt missed. Marcos ...
Ajax face Shelbourne FC on Thursday evening in the third qualifying round of the Conference League. Kick-off at the sold-out Johan Cruijff ArenA is at 20:00 and the match can be followed live on ...
Pre-season is drawing to a close, the first competitive matches have been played and the transfer market is in full swing. The new Eredivisie season is now just around the corner. In a series of ...
Sobeys on Kingston Road in Ajax will close this summer and a new grocery store within the same company will open in its place in 2027. “We are always reviewing our assets and offerings to meet the ...
Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing its first major public test, and the initial clinical data show why the pharma giant made the bet. The Ajax acquisition was a ...
YouTube is full of information on almost any topic, and the same applies to electronics. Over the years, many YouTube channels have emerged that provide engineers with how-to info on design techniques ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with strict controls ...
Eli Lilly LLY-0.39%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...
Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...
April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results